These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
338 related items for PubMed ID: 29695319
1. Reduction of mycoplasmal lesions and clinical signs by vaccination against Mycoplasma hyorhinis. Lee JA, Hwang MA, Han JH, Cho EH, Lee JB, Park SY, Song CS, Choi IS, Lee SW. Vet Immunol Immunopathol; 2018 Feb; 196():14-17. PubMed ID: 29695319 [Abstract] [Full Text] [Related]
5. Efficacy of an inactivated Mycoplasma hyorhinis vaccine in pigs. Martinson B, Zoghby W, Barrett K, Bryson L, Christmas R, Minion FC, Kroll J. Vaccine; 2018 Jan 08; 36(3):408-412. PubMed ID: 29221894 [Abstract] [Full Text] [Related]
6. Differential innate immune responses induced by Mycoplasma hyopneumoniae and Mycoplasma hyorhinis in various types of antigen presenting cells. Trueeb BS, Braun RO, Auray G, Kuhnert P, Summerfield A. Vet Microbiol; 2020 Jan 08; 240():108541. PubMed ID: 31902489 [Abstract] [Full Text] [Related]
7. Pathogenicity study of Mycoplasma hyorhinis and M. flocculare in specific-pathogen-free pigs pre-infected with M. hyopneumoniae. Fourour S, Tocqueville V, Paboeuf F, Lediguerher G, Morin N, Kempf I, Marois-Créhan C. Vet Microbiol; 2019 May 08; 232():50-57. PubMed ID: 31030844 [Abstract] [Full Text] [Related]
8. Duration of immunity for an inactivated Mycoplasma hyorhinis vaccine in pigs. Martinson B, Zoghby W, Barrett K, Bryson L, Kroll J. Vet Microbiol; 2019 Mar 08; 230():273-277. PubMed ID: 30827400 [Abstract] [Full Text] [Related]
16. Comparison of detection procedures of Mycoplasma hyopneumoniae, Mycoplasma hyosynoviae, and Mycoplasma hyorhinis in lungs, tonsils, and synovial fluid of slaughtered pigs and their distributions in Thailand. Makhanon M, Tummaruk P, Thongkamkoon P, Thanawongnuwech R, Prapasarakul N. Trop Anim Health Prod; 2012 Feb 08; 44(2):313-8. PubMed ID: 22116666 [Abstract] [Full Text] [Related]
17. Serum and mucosal antibody responses against Mycoplasma hyopneumoniae following intraperitoneal vaccination and challenge of pigs with M hyopneumoniae. Sheldrake RF, Romalis LF, Saunders MM. Res Vet Sci; 1993 Nov 08; 55(3):371-6. PubMed ID: 8284503 [Abstract] [Full Text] [Related]
18. Potential use of a recombinant replication-defective adenovirus vector carrying the C-terminal portion of the P97 adhesin protein as a vaccine against Mycoplasma hyopneumoniae in swine. Okamba FR, Arella M, Music N, Jia JJ, Gottschalk M, Gagnon CA. Vaccine; 2010 Jul 05; 28(30):4802-9. PubMed ID: 20472025 [Abstract] [Full Text] [Related]
19. Efficacy of a new bivalent vaccine of porcine circovirus type 2 and Mycoplasma hyopneumoniae (Fostera™ PCV MH) under experimental conditions. Park C, Jeong J, Choi K, Chae C. Vaccine; 2016 Jan 04; 34(2):270-275. PubMed ID: 26626212 [Abstract] [Full Text] [Related]
20. Mycoplasma hyopneumoniae potentiation of porcine reproductive and respiratory syndrome virus-induced pneumonia. Thacker EL, Halbur PG, Ross RF, Thanawongnuwech R, Thacker BJ. J Clin Microbiol; 1999 Mar 04; 37(3):620-7. PubMed ID: 9986823 [Abstract] [Full Text] [Related] Page: [Next] [New Search]